Medical communications agency InterComm International has changed ownership, with Malcolm Allison and Ben Greeves acquiring the firm.
Based in Cambridge, UK, InterComm had been under the leadership of chief executive Martin Lancaster and managing director David Mercer since 1998.
Allison and Greeves took over the reins in September as director and general manager respectively, working to deliver multichannel campaigns in the pharmaceutical and healthcare arena.
Outlining the agency’s focus, Greeves told PMLiVE: “We want to be known for delivering excellence with integrity.
“We have a great team with experience across many different clients, covering assets including medical devices, pharmaceuticals, animal health and consumer brands.”
Greeves first joined InterComm six years ago after establishing his own digital solutions firm, while Allison brings over 30 years of pharmaceutical marketing experience to the agency.
With strategic and tactical marketing and sales experience accrued while at Actelion, Bayer, GlaxoSmithKline, Novartis and Pfizer, Allison described his agency-side move as “a natural progression”.
He told PMLiVE: “We want to help clients tell their story. As InterComm moves forward under new management, we will continue working in this fast-paced industry, delivering materials that excite, educate and inform.”